Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
11.1M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
3.86M
-
Shares change
-
+548K
-
Total reported value, excl. options
-
$14.7M
-
Value change
-
-$4.08M
-
Number of buys
-
30
-
Number of sells
-
-18
-
Price
-
$3.81
Significant Holders of PRECISION BIOSCIENCES INC - Common Shares (DTIL) as of Q4 2024
61 filings reported holding DTIL - PRECISION BIOSCIENCES INC - Common Shares as of Q4 2024.
PRECISION BIOSCIENCES INC - Common Shares (DTIL) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.86M shares
of 11.1M outstanding shares and own 34.78% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (766K shares), TANG CAPITAL MANAGEMENT LLC (673K shares), Aquilo Capital Management, LLC (536K shares), GOLDMAN SACHS GROUP INC (302K shares), VANGUARD GROUP INC (278K shares), ACADIAN ASSET MANAGEMENT LLC (249K shares), CITADEL ADVISORS LLC (154K shares), RENAISSANCE TECHNOLOGIES LLC (110K shares), Alyeska Investment Group, L.P. (100K shares), and Moloney Securities Asset Management, LLC (87.8K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.